Proliferative advantage rather than classical drug resistance as the cause of treatment failure in chronic myelogenous leukemia. (Q53485322)
Jump to navigation
Jump to search
scientific article published in January 1993
Language | Label | Description | Also known as |
---|---|---|---|
English | Proliferative advantage rather than classical drug resistance as the cause of treatment failure in chronic myelogenous leukemia. |
scientific article published in January 1993 |
Statements
Proliferative advantage rather than classical drug resistance as the cause of treatment failure in chronic myelogenous leukemia. (English)
Preisler HD
Raza A
Baccarani M
1 January 1993
11 Suppl 1
303-306
1 reference
1 reference
1 reference
1 reference
1 reference